Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

14.58 +0.33 (+2.32%)
Streaming Delayed Price Updated: 12:45 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ClearPoint Neuro Inc. - Common Stock

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
Via ACCESS Newswire
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
Via ACCESS Newswire
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
Via ACCESS Newswire
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
Via ACCESS Newswire
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
Via ACCESS Newswire
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Via ACCESSWIRE
ClearPoint Neuro Reports Third Quarter 2024 Results
Via ACCESSWIRE
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024
Via ACCESSWIRE
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
Via ACCESS Newswire
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
Via ACCESS Newswire
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
From ClearPoint Neuro, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.